Analyst Ratings For KP Tissue (TSE:KPT)
Today, Desjardins raised its price target on KP Tissue (TSE:KPT) to C$18.50 per share.
There are 1 hold rating, 4 buy ratings on the stock.
The current consensus rating on KP Tissue (TSE:KPT) is Buy (Score: 2.80) with a consensus target price of C$17.50 per share, a potential .
Some recent analyst ratings include
- 3/10/2017-TD Securities Reiterated Rating of Hold.
- 11/28/2016-RBC Capital Markets Upgrade from a “Sector Perform ” rating to a ” Outperform” rating.
- 11/28/2016-Royal Bank of Canada Upgrade from a “Sector Perform ” rating to a ” Outperform” rating.
About KP Tissue (TSE:KPT)
KP Tissue Inc is a Canada-based company, created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. (KPLP). KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom and facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets. KPLP operates through three segments: consumer products sold through traditional retail channels, such as grocery stores, mass merchandisers, club stores, drug stores and convenience stores (Consumer); AFH, and Other. The Consumer segment consists of brands, such as Cashmere, Purex, Scotties, White Cloud and White Swan. AFH sells commercial tissue products through distributors to businesses involved in property management, healthcare, food service, manufacturing and lodging, and to other public facilities. The Other segment includes sale of parent rolls to tissue manufacturing companies, as well as the sale of recycled fiber.
Recent Trading Activity for KP Tissue (TSE:KPT)
Shares of KP Tissue closed the previous trading session at 15.30 down -0.11 -0.71% with 35,203 shares trading hands.
